-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Connaught, an innovative surgical robot company, completed a round B financing of 500 million yuan.
Why "Connaughton" was favored by Meituan
Why "Connaughton" was favored by MeituanConnaught, which was "fancy" by Meituan this time, is a robotics research and development company focusing on surgery, rehabilitation and clinical treatment.
The founder, Ou Guowei, is a Ph.
At present, Connaught Stern has established R&D centers in Shenzhen, China, Hong Kong, and the United States, and formed a professional team of hundreds of people.
Connaught's current round of financing is mainly used for surgical robot product research and development, clinical trials, market promotion, new product layout and industry-leading technology platform construction
Many manufacturers compete in the surgical robot market
Many manufacturers compete in the surgical robot marketMedical surgical robots overcome the problems of poor accuracy of traditional surgical operations, long operation time, doctor fatigue and lack of three-dimensional precision vision, which brings better clinical outcomes to patients and greatly shortens the doctor’s learning curve for complex operations.
On November 2, MicroPort Medical Robot was successfully listed on the Hong Kong Stock Exchange.
In terms of products, in 2016, Tianjihang’s orthopedic surgical robot "Danji 1.
On October 27, Shandong Weigao’s “laparoscopic endoscopic surgery equipment” was approved by the State Food and Drug Administration, becoming the first approved endoscopic surgery robot in China
Minimally Invasive Medical Robots has currently launched three flagship products-Tumai endoscopic surgical robot, dragonfly eye three-dimensional electronic abdominal endoscopy, and Honghu orthopedic surgical robot.
In addition, more emerging companies in the domestic surgical robot field, including the Lancet Robot and Huazhi MicroPort, have received financial support
Summary of current domestic medical robot investment and financing events
However, at present, the domestic surgical robot market is mainly occupied by Da Vinci surgical robots
On the other hand, the Da Vinci surgical robot is also actively strengthening the localization of the layout to promote cost reduction.
Medical insurance payment guides the surgical robot market
Medical insurance payment guides the surgical robot marketIn April this year, the Shanghai Medical Insurance Bureau included 28 new items in the payment scope of Shanghai’s basic medical insurance.
On October 23, the Beijing Medical Insurance Bureau issued the "Notice on Standardizing and Adjusting the Price of Physical Therapy and Other Medical Services", in which robot-assisted orthopedic surgery was included in the Beijing Class A medical insurance payment list, and patients can receive 100% full reimbursement
Note: The original text has been deleted